BioWorld MedTech

Aug. 5, 2011

Medtronic recruits Yale to review Infuse clinical trials

Medtronic (Minneapolis) reported that it is funding two independent reviews of studies of its Infuse bone graft in the wake of criticism of the clinical trials it conducted to support the device. (Medical Device Daily) Read More

Need to check your glucose? There may be an app for that

International report: Misonix enters 3-year product distribution agreement in Taiwan

Deals roundup: Emdeon enters into $3 billion merger with Blackstone Capital

Financings roundup: NeoChord raises $5M, seeks $11M for mitral regurgitation treatment

MDD's food for med-tech thought

Agreements/contracts: LABSCO to distribute systems and test kits for Diamedix

HIT roundup: ActiveCare device monitors vital signs for seniors

Product Briefs

Med-Tech Notes

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...